|
World Pharma Trials Asia 2010
World Pharma Trials Asia is an event convening pharmas, biotechs, and CROs to explore offshoring & outsourcing opportunities in Asia for cost effective preclinical and clinical drug development, at a time where Asia’s CRO market is growing at a doubling rate yearly, with more and more global pharma and biotechs are offshoring and outsourcing their drug development to Asia.
|
World Pharma Trials Asia – Your must attend event in 2010!
Gathering the top leading companies like Eli Lilly, Schering Plough, Daiichi Sankyo, Piramal Healthcare, Sanofi -Aventis and many more to talk about their global clinical strategy. Leading CROs such as Quintilles, PharmaNet, Kendle will be speaking about doing clinical trials in Asia.
Be at the World Pharma Trials Asia where pharmas, biotechs and CROs will discuss
offshoring and outsourcing opportunities in Asia for cost effective drug development strategies. These stakeholders will share how you can fast track your clinical trials in the region and effectively integrate Asia into your global drug development strategy.
» More about the programme
» Register for a seat now!
|
World Pharma Trials is part of |
|
|
|
Brochure is available for download
|
Delegates who are attending any of the four conferences in 2010, namely “Biologic Manufacturing World Asia”, “Pharma R&D Partnering World Asia”, “World Pharma Trials Asia” and “Drug Discovery Technology World Asia”, will be able to gain free access to the joint leadership roundtable session
|
|
Distinguished guest speakers
|
 |
 |
 |
Israel Makov
Chairman, Given Imaging, Chairman, Netafim, Former President and Chief Executive Officer
Teva Pharmaceutical
Industries, Israel |
Villoo Morawala Patell
Founder, Chairperson &
Managing Director
Avesthagen, India
|
Peter M. Kash
President
Riverbank Capital
Securities, USA
|
|
|
|
Confirmed speakers for 2010
|
 David Nicholson, Senior Vice President of Global Project Management, Schering Plough, USA
|
 Jeffery Kasher, Vice President, Chief Operating Officer of Global Clinical Development, Eli Lilly, USA |
 Kohei Wada, Vice President/ General Manager, Asia Development Department, Daiichi Sankyo, Japan
|
 Frank Jiang, Vice President, Head of China R&D, Sanofi-Aventis, China
|
 Victoria Elegant, Vice-President, Asia-Pacific, Regulatory Affairs, Pharmacovigilance, Baxter Healthcare Corporation, China |
 Somesh Sharma, Managing Director, Piramal Life Sciences, India
|
 Ann Wang, Vice President, Clinical Operations and Data Management, Human Genome Sciences, USA
|
 Anders Ullman, Executive Vice President, R&D, Nycomed, Germany
|
|
